» Articles » PMID: 36817288

Gluten-Free Diet in Childhood Difficult-to-Treat Nephrotic Syndrome: A Pilot Feasibility Study

Overview
Journal Glomerular Dis
Specialty Nephrology
Date 2023 Feb 23
PMID 36817288
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Minimal change disease in childhood can follow a frequently relapsing or steroid-dependent course in up to 40% of cases. Second-line immunosuppressive medications that are used to manage these patients are associated with significant adverse effects. There is a need for safer alternative treatments for difficult-to-treat nephrotic syndrome. Therefore, we conducted an open-label feasibility study to assess the safety and efficacy of a gluten-free diet as treatment for pediatric patients with difficult-to-treat nephrotic syndrome. As a second aim, we sought to determine if the plasma zonulin concentration can identify those who are more likely to respond to this intervention.

Methods: Seventeen patients were placed on a gluten-free diet for 6 months. A positive response was defined as a 50% reduction in the relapse rate compared to the preceding 6 months or the ability to discontinue 1 immunosuppressive drug.

Results: Five (29%) participants had a positive response to the dietary intervention. The gluten-free diet was well tolerated with no clinical or laboratory adverse events. Plasma zonulin concentration was elevated in patients who failed to benefit from the gluten-free diet.

Discussion/conclusion: A gluten-free diet may be a useful adjunctive intervention for patients with difficult-to-treat nephrotic syndrome that can be implemented prior to resorting to second-line immunosuppressive therapy. Development of the plasma zonulin level as a biomarker to predict efficacy would facilitate rational use of a gluten-free diet in the management of nephrotic syndrome.

References
1.
Levine J, Hauptman L, Moy L, Trachtman H . Effect of a gluten-free diet on albuminuria in children with newly diagnosed celiac disease. Glomerular Dis. 2021; 1(1):3-9. PMC: 8336695. DOI: 10.1159/000514635. View

2.
Laurent J, Rostoker G, Robeva R, Bruneau C, LAGRUE G . Is adult idiopathic nephrotic syndrome food allergy? Value of oligoantigenic diets. Nephron. 1987; 47(1):7-11. DOI: 10.1159/000184448. View

3.
Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P . Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol. 2007; 17(9):428-37. DOI: 10.1016/j.tcb.2007.06.006. View

4.
Metz D, Kausman J . Childhood nephrotic syndrome in the 21st century: What's new?. J Paediatr Child Health. 2014; 51(5):497-504. DOI: 10.1111/jpc.12734. View

5.
Fasano A . Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011; 91(1):151-75. DOI: 10.1152/physrev.00003.2008. View